RichardDSiegelMD

Diabetes, Lipid Metabolism, Obesity, Thyroid

Attending in Endocrinology, Tufts Medical Center; Staff Endocrinologist, Weight and Wellness Center

Dr. Siegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Richard Siegel is an endocrinologist based in Boston, MA, specializing in diabetes, lipid metabolism, obesity, and thyroid disorders. He completed his medical education at Albany Medical College in 1990 and his residency in internal medicine at Boston University Medical Center in 1994. He is currently an Associate Professor of Medicine at Tufts University School of Medicine. Dr. Siegel's work focuses on diabetes mellitus, obesity-related disorders, lipid metabolism, medical weight loss, and thyroid disease. He has contributed to multiple publications, including those in the Journal of the American Pharmacists Association and Clinical Chemistry. His work has been recognized with awards such as the CMS Meaningful Use Stage 1 Certification and Top MD from Consumers Checkbook.

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Top MD Consumers Checkbook

PubMed

Implementation of a pharmacist-led weight loss service to improve medication access and weight loss.
Samantha Schermerhorn, John Aurora Jr, Meghan McElligott, Richard D Siegel
Journal of the American Pharmacists Association. 2024-04-04
1 citations
Commentary on Recurrent Hypoglycemic Episodes with Hypoinsulinemia in a Patient with Diabetes
Richard D. Siegel
Clinical Chemistry. 2021-01-30
10 citations
The Calculation of the Glucose Management Indicator Is Influenced by the Continuous Glucose Monitoring System and Patient Race
Edith Angellotti, Sangeetha Muppavarapu, Richard D. Siegel, Anastassios G. Pittas
Diabetes Technology & Therapeutics. 2020-09-03

Thyroid Cancer Is Overdiagnosed in the U.S.—Could Ozempic Be Making the Problem Worse?February 25th, 2025
Two Proposals in New Massachusetts State Budget Could Affect Candy and TrafficJanuary 23rd, 2025
EXCLUSIVE: Retta Recalls Being Diagnosed with Type 2 DiabetesSeptember 23rd, 2024